An analysis of the career and publication outcomes for 2284 early career researchers trained at EMBL provides insights into the evolving career landscape for life scientists.
A strategy to identify high-quality commercially available antibodies for research reveals extensive use of non-specific antibodies and offers solutions for future large-scale testing.
Why do some inhibitors select the on-state in ERK2, a kinase that is involved in many signaling pathways in cells, whereas others bind to more than one conformation?